KEGG pathway enrichment analysis revealed that GJZLP treatment for tuberculosis could target multiple signaling pathways, primarily including Lipid metabolism, Atherosclerosis, TNF, IL-17, Toll-like receptor and C-type lectin receptor signaling pathway. This evidence concerns the gene TNF and atherosclerosis.